Press Enter to search · Esc to close
Two 2026 studies move the Med-Diet story from epidemiology toward mechanism, pointing to mitochondrial microproteins and a reshaped gut microbiota as plausible reasons the pattern protects the heart and brain.
Two new reviews suggest the next frontier in performance nutrition isn't what you eat — it's when you eat, and how the starch on your plate talks to the bugs in your gut.
Two new studies sharpen the picture of chronic low-grade inflammation in aging — one points to a routine blood ratio, the other to a specific gut microbe coaxed by ginseng. Neither is a prescription. Both are worth watching.
A new in-vitro colonic model says whey protein reshapes the gut microbiome of metabolic-syndrome adults — and stevia, the sweetener riding shotgun in half your tubs, blunts the effect.
Microbiota-targeted therapies, a newly mapped liver enzyme called HYAL1, and Mendelian evidence linking metabolic syndrome to IBD are quietly reshaping how scientists think about type 2 diabetes.